HIMS vs LFMD
HIMS: A consumer-first digital health platform connecting patients to licensed providers for prescription medications and wellness services across sexual health, weight loss, hair loss, and mental health via telehealth consultations. LFMD: LifeMD is a telehealth platform connecting patients with licensed providers for remote consultations and prescription medications delivered nationwide.
Side-by-side fundamentals
| Metric | HIMS | LFMD | Edge |
|---|---|---|---|
| Price as of 2026-07-27 close | $30.24 | $3.87 | |
| Market cap as of 2026-07-31 | $6.3B | $176M | |
| P/E as of 2026-07-31 | 48.76 | 33.79 | LFMD lower |
| PEG as of 2026-07-31 | n/a | -0.35 | |
| Net margin as of 2026-07-31 | -0.6% | +2.4% | LFMD higher |
| Gross margin as of 2026-07-31 | +72.9% | +70.5% | HIMS higher |
| Operating margin as of 2026-07-31 | -1.3% | -8.7% | HIMS higher |
| ROE as of 2026-07-31 | -2.5% | +55.3% | LFMD higher |
| ROA as of 2026-07-31 | -0.6% | +7.4% | LFMD higher |
| Debt / equity as of 2026-07-31 | 2.18 | 0.00 | LFMD lower |
| Revenue growth (YoY) as of 2026-07-31 | +32.8% | -6.2% | HIMS higher |
| Revenue CAGR (3y) SEC XBRL | +64.5% | +17.7% | HIMS higher |
| Dividend yield as of 2026-07-31 | n/a | +1.8% | |
| Beta as of 2026-07-31 | 2.49 | 2.03 | |
| 1-year return as of 2026-07-27 close | -47.5% | -63.8% | HIMS higher |
Fundamentals: market data, as of 2026-07-31. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-27.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.